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creativecommons.org/licenses/by-nc-cities across the country, offering a wide range of assistedIntroduction
Mexico has a fairly well-established reproductive healthcare
industry, with assisted reproductive technology as the main
product. There are over 50 clinics operating in various6.10.002
blished by Elsevier Ltd. This is
nd/4.0/).reproductive technology treatments and with a prominent
profile in the national media. There is an active professional
association, established in the late 1940s, with approximately
450 members and its own specialised journal. According to thean open access article under the CC BY-NC-ND license (http://
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in 2013 Mexico conducted 7204 cycles to prepare women
for either IVF or for intracytoplasmic sperm injection (ICSI)
making it the country with the third-highest number of
reported cycles within the registry (Zegers-Hochschild et al.,
2016). This ranking should be considered with some caution
however, because it was derived from data offered voluntarily
by only 29 clinics, about half of those that exist in the country.
When and how did assisted reproduction become common
practice within the area of reproductive medicine? How did
the Mexican assisted reproduction industry emerge and
become this active? This paper explores these questions from
the service providers’ perspective (the perspective of the user
is equally important, although it will not be discussed here).
Two aspects are highlighted that are suggest were important
for the establishment of the Mexican assisted reproduction
industry and for its subsequent development. The first one has
to do with an epistemic shift that made these technologies
acceptable to the practicing medical community. The second
refers to the way in which the assisted reproduction bio-
medical community choreographed (Thompson, 2005) the
practical, technological and economic elements that are
implicated in the provision of assisted reproduction services
and thus established the assisted reproduction industry.
The account of Mexico’s ‘repronational history’ (Franklin
and Inhron, 2016) offered in this paper is informed by the
ethnographic work carried out at public and private clinics,
medical and non-medical conferences, professional meet-
ings and at online forums and websites, as well as from
interviews with users and psychologists, the analysis of
national journals, newspapers, magazines and legal docu-
ments. This account begins in the late 1940s and continues
until the early 2000s, a period strongly marked by a shifting
reproductive agenda, the growth of biomedicine, the
strengthening of globalisation and neoliberal practices, and
a constant yet unsuccessful struggle for democracy.
The structure of the paper traces how the practice of
biomedically assisted reproduction evolved locally. Part 1
describes the epistemic shift that allowed the biomedical
community concerned with infertility to make sense of and
accept the new technologies of assisted reproduction that
were being pioneered overseas. Part 2 looks at the emergence
and establishment of the biomedical assisted reproduction
industry. Due to the complexity of the Mexican healthcare
systems the important points of each system are summarized
in Table 1 for clarity. Likewise, in Table 2, an overview of
the history of assisted reproduction in Mexico is provided,
highlighting the major events that are discussed in this paper.
The epistemic shift: from esterilología to
reproductive biology
This account begins in the late 1940s, looking at the
professional activities of a small group of physicians con-
cerned with and dedicated to understanding and curing
what they called ‘conjugal sterility’ (esterilidad conyugal).
Interestingly, this group strongly opposed artificial insemi-
nation (AI), a technique that had proven successful in certain
cases. This group of specialists witnessed and participated in
the fundamental transformation of Mexico’s reproductive
agenda, a transformation that, as will be described, wasimportant for the development of assisted reproduction in
Mexico.Esterilología: the study of conjugal sterility
According to census figures from 1910 and 1921, respective-
ly, when the 10-year Mexican Revolution ended in 1920, the
population had decreased from 15.1 million to 14.8 million
(Alba-Hernandez, 1976; Mendoza García and Tapia Colocia,
2010). This situation lead the state to issue two sets of laws
that would help increase the population, one in 1936 and the
second in 1947, which favoured reproduction by limiting the
availability of contraception and by promoting healthcare
practices to tackle perinatal and infectious diseases. They
also stimulated immigration and the repatriation of those
who left during the revolution. The effects of these policies
were as expected: a decrease in mortality and an increase in
the total population. By 1950, Mexico’s population totalled
25.8 million; nonetheless, Mexico’s official agenda contin-
ued to be pro-natalist (Mier y Terán, 1991).
It was in this context in 1949 that an all-male group of 31
physicians established the first national biomedical profes-
sional association focused on infertility, as well as one of the
very first journals on this topic. They named the association
The Mexican Association for the Study of Sterility (Asociación
Mexicana para el Estudio de la Esterilidad, henceforth AMEE)
and their quarterly journal Sterility Studies (Estudios en
Esterilidad, henceforth EE). Among other things, they were
concerned with the effects ‘conjugal sterility’ had on the
individual, the couple and the nation. At the individual
level, clinicians recognized that childlessness affected both
women’s and men’s identity and drive in life; for a couple it
meant the nullification of one of the primary purposes of
pairing; and for society as a whole it represented a loss of
valuable human resources that could link past and present,
perpetuate cultural traditions and give the nation solidity
and strength (Álvarez Bravo, 1952; Sordo Noriega, 1951).
The formation of the association and the publication of
its journal confirmed the emergence of esterilología as
‘the specialty of gynaecology, and... of andrology’ (Arteaga
Elizondo, 1961:60) dedicated to the interdisciplinary study
of ‘marital infertility’ or ‘conjugal sterility’, involving areas
such as radiology, endocrinology, psychiatry, biology, psy-
chology and chemistry (Castelazo Ayala, 1959; Castro,
1959). As an emerging specialty, esterilología required a
corpus of basic scientific research, for which standardized
diagnostic methods and criteria were needed. Most of the
research reported in EE was based on the members’ clinical
experience from both their private practice and their work
in the publicly-funded healthcare system. In these two
settings they encountered a population of patients diverse in
terms of income and socio-cultural background. Within this
diverse population, they found an equally diverse set of
causes for infertility: from poor eating and hygiene habits,
alcoholism, work-related issues (mainly in men) and lack of
knowledge regarding intercourse, to the negative side
effects of abortions (which were illegal), delaying marriage
and the use of contraception – which they saw as causes of
endometriosis (Álvarez Bravo, 1952).
As mentioned above, the association spoke of ‘marital
infertility’ or ‘conjugal sterility’. These terms suggest a
Table 1 The Mexican healthcare system.
Healthcare
scheme
Institutions and hospitals
offering assisted
reproduction
User eligibility Fees Assisted reproduction
services offered
Privately owned
services
These are privately owned
medical groups all of which
house assisted reproduction
clinics:
• Médica SurGrupo
• ÁngelesStar Médica
• American British Cowdray
Hospital
• Hospital Español
This group also includes
privately owned clinics
that are not affiliated to a
hospital.
Anybody who can pay for
it or has private
insurance that covers it.
The user pays for the
service out of pocket or via
their private insurance
company.
Fees are established by
the doctor and/or the
hospital and medication is
bought from private
pharmacies at market
price.
Low and high complexity
assisted reproductive
technologies.
Work-related
social security
system
Each scheme has its own set
of hospitals throughout the
country and all offer some
sort of assisted
reproduction services,
although some only
intermittently.
People working in the
following sectors have
the right to use the
social security scheme
assigned to that sector:
State workers: Instituto
de Seguridad y Servicios
Sociales de los
Trabajadores del
Estado, (ISSSTE)
Workers in the private
sector: Instituto
Mexicano del Seguro
Social (IMSS)
Workers in the Petrol
Industry: Petroleos
Mexicanos (PEMEX)
Members of the military:
Secretaría de la Defensa
Nacional (SEDENA)
Varies, depending on
institution.
ISSSTE: offers high
complexity assisted
reproductive technologies
since 1996. Their services
were set up with the
assistance of Dr Gutierrez
Najar.
IMSS: only offers low
complexity assisted
reproductive technologies.
PEMEX offers low and high
complexity assisted
reproductive technologies.
The service is outsourced to
private clinics.
Public social
security system
Secretaría de
Salubridad y
Asistencia (SSA)
Constituted by 12 institutes
for the research and care of
health related issues, and
14 general and specialised
hospitals, including 3
psychiatric.
The one concerned with
assisted reproduction is the
National Institute of
Perinatology (INPer)
Offered to people that
are not eligible to the
IMSS or ISSSTE health
security system.
There are restrictions on
age, marital status,
number of cycles and
type of treatment.
Fees are charged
depending on the users’
income bracket and
medication is offered at a
reduced price.
Low and high complexity
assisted reproductive
technologies.
No gamete donation,
embryo freezing or
surrogacy are offered.
118 SP González-Santosparticular way of viewing infertility, thus influencing how
physicians diagnosed and treated it. Physicians considered
infertility to be a predominantly curable condition of the
couple. They highlighted that ‘the fertilizing capacity
corresponds jointly to both the husband and the wife’
(Guerrero, 1954:29), hence their guidelines stipulated that
‘the study of the sterile couple must be directed to both’
(Valdes la Vallina, 1954:15), the couple are considered as a
unit. This particular view accounted for the frequent use ofpost-coital tests, which in addition to enabling conformity
with the religious prohibition on masturbation, complied
with the association’s view that infertility could be cured if
the right diagnosis was reached. As stated in a 1954 article
published in EE: ‘conducting routinely post-coitus studies of
the ejaculated in the vaginal fluids [...] allows us to asses
the behaviour of the sperm in the medium it must act in, and
not in a crystal box [...] we need to study, in the mix of
male-female secretions, the morphology, quantity, motility
Table 2 Overview of the history of assisted reproduction in Mexico.
Time
frame
Association Assisted reproduction context Legal and political context
1940–1966 Asociación Mexicana de
Estudios en Esterilidad –
AMEE
Mexican Association for the
Study of Sterility
Infertility was considered a medical
problem concerning both women and men,
with negative effects for the individual, the
couple and the nation. It was called
conjugal infertility or marital sterility.
Esterilología was the multidisciplinary
medical speciality dedicated to studying
and treating conjugal infertility.
Since artificial insemination was not viewed
as a curing procedure, it was considered
unacceptable.
1950–1970 The first journal dedicated to
the study of infertility was published:
Estudios en Esterilidad
1961 The first AMEE annual conference was
held (the 53rd conference was held in 2016)
Population growth was desired, hence there
were two sets of laws that strictly regulated
and restricted contraception methods. The
first was published in 1936 and the second
in 1947.
1966–1992 Asociación Mexicana para el
Estudio de la Fertilidad y
Reproducción Humana –
AMEFH
Mexican Association for the
Study of Fertility and
Human Reproduction
Reproductive biology is included in the
general curricula of the medical degree and
as a topic of inquiry in the research centres
focused on reproductive biology.
Reproduction was being studied and
controlled through hormonal and surgical
methods.
Between 1985 and 1986 the first private
assisted reproduction clinics were
established, one in Mexico City and the
other in Monterrey, Nuevo León.
1988 Mexico’s first assisted reproduction
success stories:
Carlos Esteban, conceived via GIFT, was
born on 24 of February and Andrea,
conceived via IVF, was born on the 23 March
Population growth was starting to be
framed as a problem, hence biomedical and
political attention was shifted towards
controlling fertility.
In 1974 laws were passed to promote family
planning strategies (Ley General de
Población), a government body was created
to overlook the family planning campaigns
(CONAPO) and the media was used to
promote these campaigns (using Mexican
soap operas known as telenovelas).
1992–to
date
Associacion Mexicana de
Medicina Reproductiva –
AMMR
Mexican Association of
Reproductive Medicine
From 1993 on, new private assisted
reproduction clinics began to open in
Mexico City and other major cities across
the country.
In 2008 the first issue of the association’s
new journal, Reproducción, was published.
In 1999 the first proposal to legislate
assisted reproduction was presented by the
Green Party. Since then, over twenty
proposals have been presented.
In 2000 CENATRA was created.
In 2001 COFEPRIS was created.
CENTARA = National Transplant Centre; COFEPRIS = The Federal Commission for the Protection of Sanitary Risk; CONAPO = National Population
Council; GIFT = gamete intrafallopian transfer.
119The story of the Mexican assisted reproduction businessand vitality modifications of the male cell in question.’
(Valdes la Vallina, 1954:18).
Considering (in)fertility as a conjugal matter meant that
single women were not eligible for the diagnosis of infertility,
let alone its treatment. While they viewed maternity as
a deeply rooted natural female instinct, practitioners of
esterilología could not even consider that single women could
desire children since this desire resulted necessarily from
marriage and if she had relinquished marriage, how could she
bear the responsibilities of being a mother? (Arteaga Elizondo,
1961).
Their understanding of ‘marital infertility’ also influ-
enced how they viewed AI. Members of AMEE considered that
using AI in humans was morally problematic. First, they
acknowledged that the Catholic Church disapproved of it(Pope Pio XIII, 1956). Second, they considered that using
donor sperm could imply adultery and create uncertain
paternity. Third, they believed that practicing AI was
‘professionally immoral’ (Arteaga Elizondo, 1961), arguing
that physicians were meant to cure infertility, not simply
bypass it. In the words of an AMEE member: ‘the solution
to the problem is not to practice artificial insemination,
but to fix the problem that is preventing normal insemination
[...] adopting [AI] is to manifest the uselessness of our
resources and treatments within the field of male infertility’.
(Guerrero, 1953).
While the AMEE and the government were focused on
curing infertility and promoting reproduction respectively,
academics and politicians in the USA and Europe were
becoming concerned with the ‘demographic explosion’ in
120 SP González-SantosAsia and Latin America and began to pressure these
countries to introduce family planning programmes and
policies that would halt population growth (de Barbieri,
2000; Caldwell, 2001; Najam, 1996; Soto-Laveaga, 2007).
This fear motivated investments in biological and socio-
anthropological research projects focused on human repro-
duction to be carried out in these countries, with the
purpose of improving contraception methods and developing
successful family planning programmes. However, ideas
around controlling reproduction were not entirely novel to
the population. Even when Mexico’s official agenda was still
pro-natalist and the sale of contraceptives in public health
centres was still illegal, some people were already using
various contraceptive methods such as rhythm, withdrawal,
intrauterine device and surgical sterilisation (CONAPO,
1999; Zavala de Cosío, 1992). Likewise, during this time a
team of Mexican scientists led by Luis Ernesto Miramontes
Cárdenas, Carl Djerassi and Jorge Rosenkranz were synthesis-
ing one of the main molecules necessary for the development
of the contraceptive pill by the Mexican pharmaceutical
company Syntex (Arredondo-Rivera and Juárez-Sánchez,
2009).
It was within this context that the concern from overseas
regarding Mexico’s demographic explosion reached the AMEE.
In 1953, Dr Abraham Stone, a physician from New York,
published the first article in the journal EE to talk about the
urgent need to balance population sizewith natural resources,
between (industrial) production and (human) reproduction
(Stone, 1953). However, it took 10 years for the association
to revisit this topic, possibly due to several factors. First,
because some were not sure overpopulation was a problem in
Mexico; second, because they feared antagonising religious
sensibilities; and third, because they did not see a contra-
diction between what they did and the family planning
suggestions for which foreign countries pressured (Fournier
Mateos, 1964). By the mid-sixties public discussion of this
‘demographic explosion’ was already so loud and politically
so important, both internationally and nationally, that AMEE
began to listen. Hence, as part of their annual meeting in
1964, the AMEE convened a special multidisciplinary sympo-
sium to address Mexico’s demographic situation. They wanted
to obtain first-hand information that would help them
determine if Mexico actually had a demographic problem
and, if so, to what degree. Parallel to this, reproductive
biology became recognized as a biomedical speciality as
suggested by the following events: first, the creation of an
independent department dedicated to this area of research
and the establishment of a fertility service in two of the
most important hospitals, one in the Instituto Nacional de
Nutrición Salvador Zubiran (INNSZ) (National Institute of
Nutrition Salvador Zubiran), which had 20 years of experi-
ence researching hormones and reproduction, and the other
in the Instituto Mexicano del Seguro Social-Centro Médico
Nacional (IMSS-CMN) (Mexican Institute of Social Security)
(Gual-Castro, 2000); second, with the establishment of the
academic field of reproductive biology in the Faculty of
Medicine at the Universidad Autónoma Nacional de México
(UNAM) (National Autonomous University of Mexico), initially
as a specialisation programme and then as masters or doctoral
degree (Gual-Castro, 2000).
Although AMEE members had originally been somewhat
sceptical of the ‘demographic explosion’ discourse and theproposal to impose family planning as a solution, the political,
professional and academic changes that took place during the
1960s described above contributed to the prevailing of this
discourse, leading to a significant shift in the professional
culture of Mexican esterilología. This shift can be appreciated
through both the content of the journal and the ethos of the
association. From 1965 to 1970, when the last issue of EE was
published, there was a steady increase in the number of
articles concerned with contraception. Likewise, AMEE’s
1967–1969 administrative board featured doctors who were
already offering oral contraceptives to their patients and
during their fifth annual meeting held in 1968 there weremore
speakers addressing contraception than ever before. However,
the most important event that reflects this shift takes place in
1966 when, under the leadership of Dr López de Nava, the
association decided to change its name to Mexican Association
for the Study of Fertility and Human Reproduction (Asociación
Mexicana para el Estudio de la Fertilidad y Reproducción
Humana, henceforth AMEFRH). During his acceptance speech
as newly elected president in 1967, Dr Francisco Durazo Quiroz
argued that the new name reflected more accurately the
association’s activities and interests, which had moved from
focusing on sterility and reproduction (the esterilología
perspective) to focusing on fertility and contraception
(Durazo Quiroz, 1967).From esterilología to sterilisation
After the United Nation’s World Population Conference held
in Bucharest in 1974, three important political moves were
made to reinforce the new perspective on population
growth. First, the General Population Law was enacted
(Ley General de Población), obliging the state to offer family
planning services for free (Gutmann, 2009; Pick de Weiss,
1987; Vallarta-Vázquez, 2005). Clinics and physicians were
given targets for female sterilization or incorporation into
the family planning programme. As a result, Mexican women
accessing the public healthcare system began to be offered
contraception systematically at every medical consultation
they attended (a practice commonly referred to as the
‘oferta sistemática’ policy). Second, the 4° article of the
Constitution was amended to state that every person has the
constitutional right to decide the number and spacing of
children they have (CONAPO, 1999). Third, the National
Population Council (Consejo Nacional de Población, CONAPO)
was created and made responsible for transforming people’s
attitudes towards family planning methods in order to achieve
the new ideal family composition: mother, father and two
children (Soto-Laveaga, 2007).
This growing acceptance of and interest in controlling
reproduction biomedically led the administrations of the
various social security systems (see Table 1) to establish
research centres and family planning clinics. In parallel,
reproductive biology became a specialisation programme
within the Faculty of Medicine at the National Autonomous
University of Mexico (UNAM) (Gual-Castro, 2000). The
research and training being done via these research centres
and specialisation programmes were mostly focused on
controlling fertility through endocrinological and surgical
procedures. Knowing how to manage contraception through
hormonal control and surgical procedures turned out to be
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of the assisted reproduction pioneers told me during an
interview:
contraception and infertility are both related to hormones, they
are the two sides of the same coin [...] we did lots of research in
endocrinology, hormones and reproduction [...] we created a
contraceptive program [...] It was there that I started treating
patients with infertility problems. Back then it was only artificial
insemination (Interview with Dr GN, field notes 2007).
This emerging view of reproductive health encompassed
fertility and infertility, conception and contraception –
drawing links between them as two different ways of
controlling reproduction via hormonal management and
surgical interventions.The dawn of assisted reproduction: the
establishment of reproductive biology
Between the late 1950s and 1970s, a number of Mexican
physicians completed internships in the USA with leading
reproductive endocrinologists such as Robert Greenblatt, who
developed protocols for ovarian stimulation using clomiphene
citrate (Zárate and Saucedo, 2007). When these physicians
returned to Mexico, they created programmes and laborato-
ries dedicated to issues concerning reproductive endocrinol-
ogy and they established working collaborations with these
overseas experts (for example, Dr Efraín Vázquez Benitez from
the Hospital Español). These collaborations resulted in
invitations for them to come to Mexico:
in order to start the reproductive unit at the Institute, the [...]
director invited specialists to train his team, [they invited]
Dr José Balmaceda and Dr Ricardo Asch, the creators of GIFT [...]
(Interview with Dr PDC, field notes, 2008).
At that time, Dr Asch had also been working with
Dr Greenblatt. Years later he developed centra (GIFT) with
Dr Jose Balmaceda, a technique that seemed quite promis-
ing back in the late 1980s (Yovich, 1994) and, for some
people, it implicated fewer moral uncertainties since
fecundation occurs inside the woman’s body – as opposed
to the situation in IVF. Both Dr Asch and Dr Balmaceda
participated in the process of importing and translating
assisted reproductive technology into Mexico by making it
accessible to local gynaecologists and biologists. Since they
were Latin American, Argentinian and Chilean respectively,
they could communicate with the Mexican teams easily and
they were aware of the cultural elements shaping the local
patient-physician relationship. One of their major contribu-
tions was to introduce GIFT.
Another physician who visited Dr Greenblatt at the
University of Georgia was Dr Samuel Hernández Ayup and
while there he also met Dr Asch. When he returned to Mexico
he established, together with Dr Santos Haliscak and Dr Pedro
Galache, what is now the Institute for the Study of Human
Conception (Instituto para el Estudio de la Concepción
Humana, IECH–formerly the Instituto para el Estudio de la
Reproducción Humana, INPERH) in the wealthy conservative
northern city of Monterrey. It was they who in 1987 claimed‘the first’ successful pregnancy using assisted reproductive
technology (specifically GIFT): Carlos Esteban, born on 24 of
February 1988 (Diaz Spindola et al., 2011). This first success
was reported in a paper published in the journal of the
Academy of Gynaecologists and Obstetricians (Hernández
Ayup et al., 1989) which describes a cohort of 72 patients
who underwent GIFT, 19 of whom became pregnant (three
with multiple pregnancies). By the time the paper was
published, 11 babies had been born. In this paper the authors
give extensive credit to Dr Asch as the creator of GIFT and as a
direct influence in the positive outcome of the cases reported
in the paper: ‘We thank themedical and technical aid given by
doctors Ricardo Asch, José Balmaceda, Francisco Rojas...’ and
five more people, one of whom was a chemist (Hernández
Ayup et al., 1989). Interestingly, in the paper they never claim
to be the first in Mexico to accomplish such a task, however in
that same issue, they do say they are reporting the first
national success using ova donation (Santos Haliscak et al.,
1989). IECH is still one of the leading clinics in the country; it
has facilitated the conception of over 1700 babies and the
training of 37 specialists (IECH website).
A month after Carlos Esteban’s birth, another ‘first’
accrued. This time it was the birth of Andrea, the first
Mexican baby conceived using IVF (Cuneo-Pareto and
Gaviño-Gaviño, 2015), and born on 23 March in Mexico
City. In this case, the team responsible for it was headed by
Dr Gutierrez Najar, a key figure in both the development of
family planning programmes as well as in the establishment
of assisted reproduction in Mexico (Cruz, 2003). As far as
is known, this case was not reported in the academic
literature. Like the doctors at the IECH in Monterrey,
Dr Guiterrez Najar assisted in the conception of over 3000
babies and trained many specialists who then went on to
open their own clinics (AMMR, 2014). Between 1986 and
1992, the IECH and Dr Guiterrez Najar’s clinics were the only
two private clinics operating in Mexico. In addition to these,
there was an assisted reproduction service within the public
healthcare systems (SSA), offered at the National Institute of
Perinatology (INPer, SSA) (see Table 1). Its assisted repro-
duction unit was created in the mid 1980s under the
direction of Dr Alberto Kably Ambe, placing INPer as the
third place where assisted reproduction was pioneered in
México. Because it is a teaching hospital, it has been central
as a training site for many people interested in reproductive
biology, and because it receives federal funding, it can offer
assisted reproduction services at a lower cost, benefiting
people with fewer economic resources.
In 1992, only a few years after these first successful cases
of assisted reproduction, the former AMEE, later AMERFH,
changed its name again, now to Mexican Association of
Reproductive Medicine (Asociación Mexicana de Medicina de
la Reproducción, henceforth AMMR). Each change of name
reflects a shift in perspective. While the previous names
focused on studying the dyad infertility-fertility, the new
and current name focuses on understanding and manipulat-
ing the general process of reproduction from a biomedical
perspective. As mentioned previously, the EE journal closed
in 1970 and the members of AMEFRH had to migrate their
publications to Gynaecology and Obstetrics of Mexico
(Ginecología y Obstetricia de Mexico), a more general, but
better-established, journal. However, by 2008 the associa-
tion revived the idea of having its own specialised journal,
122 SP González-Santosand thus began publishing Reproduction (Reproducción).
While the members of the AMMR link themselves to the
AMEE, they make an open effort to cut ties with the
association’s previous publication, EE. This effort is clearly
stated in the introductory article published in the first issue
of Reproduction: ‘[...] due to the extent of its focus which
reflects the evolution of the association, we cannot consider
this journal to be a second stage or period of the previous
journal. Instead, this is a new space where [...] our national
and international research fellows can publish’ (Vázquez
Benítez, 2008:11). The reasons stated for this distinction
again suggest the change of perspective from esterilología
to reproductive biology.
During the last six years of the twentieth century,
Mexico’s fertility rate decreased to 2.4 children per woman
and the government shifted its attention from population
control to reproductive health (CONAPO, 1999). Within this
new paradigm, reproductive rights, family planning, mater-
nal and child health, infertility and sexually transmitted
infections and diseases, were all united under the same
conceptual frame and established the foundations for the
new Reproductive Health Programme (Programa de Salud
Reproductiva). Its purpose was to offer information and
orientation regarding prevention, diagnosis and handling
of infertility. During this period, the number of assisted
reproduction clinics multiplied almost six-fold: from 3 clinics
in 1994 to 17 in 2000.
As described above, between 1970 and 2000 the question of
how to tackle infertility changed both steadily and signifi-
cantly among professional groups, government agencies
and the general public. Low and high complexity assisted
reproductive technology became less morally controversial;
instead, the techniques were considered as a way of giving
patients the child they desired. This change occurred con-
currently with the change from the family planning paradigm
to the reproductive health paradigm. Hence, the general
message being sent was one that underscored that biomedical
knowledge and technology were able to control reproduction
– a message which, as Adele Clarke has argued, positioned
reproduction increasingly as a phenomenon to be explored,
managed and disciplined (Clarke, 1998).
The end of the twentieth century marked a clear turning
point for assisted reproduction in Mexico. The country began
the new century with at least two public healthcare services
offering assisted reproductive technology, seventeen pri-
vate clinics scattered throughout eight cities, a professional
association dedicated to reproduction (AMMR), one proposal
to legislate the existing clinics (more on this below),
professionalization programmes at three universities and
some media coverage of the matter. All this suggests that by
the year 2000, Mexican assisted reproduction had reached a
new phase (see Table 2).Part 2 – the assisted reproduction industry
The previous section traced the epistemic turn that resulted
in esterilología transforming into reproductive biology
(highlights summarized in Table 2). This section looks at the
establishment and consolidation of the assisted reproduction
industry and the way it is regulated. This part of the story
begins in the last decade of the twentieth century and coversthe first decade of the twenty-first. During this period,
treating infertility moved beyond the gynaecological ser-
vice within hospitals and healthcare systems into the highly
specialised assisted reproduction clinic. But above all, it
developed into a healthcare service that resembles a commer-
cial industry, particularly assisted reproduction clinics within
the private sector.
Towards the end of the 1990s, a second wave of clinics
(approximately 11 in number) started to emerge in places
other than Mexico City andMonterrey thus enabling the spread
of assisted reproductive technology nationwide. Many of these
clinics were established by the first generation of specialists
trained at the clinics and servicesmentioned above. It must be
remembered that assisted reproductive technology is expen-
sive, requiring significant financial investment in equipment
andmaterials and in employing a large number of staff; hence,
practitioners interested in opening their own clinic who lacked
the means to do so independently, had to find ways of coping
with the significant financial and logistical challenges. Some
physicians opened branches of larger clinics, following what I
describe as the ‘networkmodel’. Under thismodel there is one
large well-equipped head-quarter clinic, which centralizes
provision of themost expensive procedures and distributes the
less technologically demanding parts of the treatments across
many smaller satellite clinics. Other emerging professionals
decided on an alternative ‘outsourcing model’; when physi-
cians outsource assisted reproductive technology they either
rent the equipment and perform the procedures themselves or
they send the gametes to equipped clinics and have them
perform the procedures (Cf. González-Santos, 2011). Here we
can see the emergence of the first characteristic of an assisted
reproduction clinic: it is a multidisciplinary group of collabo-
rating specialists that includes physicians, biologists, nurses
and administrative staff.
As stated before, many of the clinics that opened towards
the end of the twentieth century were established by
doctors who had been trained at one of the first three
facilities mentioned above. One exception was a clinic
established in Guanajuato by doctors who had returned from
training at a clinic in Valencia, Spain. The distinguishing
characteristics of the way in which the Spanish clinic
operated were its emphasis on becoming a multinational
business, its strong use of marketing to promote services,
and managerial strategies that allowed them to offer
services at a lower cost. Even though physicians and
biologists judged the Spanish clinic’s clinical and laboratory
practices to be interesting, they also considered that they
needed to be adapted in order to meet local needs and
requirements. For example, in terms of how patients were
managed, ‘Mexicans require a different bedside manner...
they like being seen by the same doctor all through their
procedure’ (Biologist, field-notes, 2007). Interestingly, as
will be described below, Mexican clinics did eventually
operate in the ‘Spanish’ fashion, in which patients are seen
by more than one doctor throughout the cycle of treatment.
A few years later, as a result of market research, the Spanish
clinic opened its own branch in Mexico City and established
its own training programme, all this as part of their efforts to
establish a multinational assisted reproduction corporation.
Recently, however, they merged with a local clinic that
holds branches in several cities across the country (www.ivi-
fertilidad.com/es-mx/pacientes/, accessed 26 June, 2016).
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this stage of Mexican assisted reproduction, each in their
own particular way. The USA influenced Mexican practice
through physicians who came to Mexican clinics and through
Mexican physicians going to the USA for training. Likewise,
the influence of the USA was established in the alliances
some Mexican clinics had with some USA clinics. The Spanish
influence can be seen in the training received by some
biologists and physicians, but mostly in the marketing
strategies employed by the Mexican branch of the Spanish
clinic and by those who trained there.
The maturing of the first generation of assisted repro-
duction specialists trained by the forefathers at the clinics
mentioned above resulted in the spread of assisted repro-
duction clinics beyond the original services and out of Mexico
City and Monterrey. It was the first wave of private assisted
reproduction clinics opening across the city and the country,
slowly adding up to over 50 registered in The Federal
Commission for the Protection of Sanitary Risk (COFEPRIS) in
2015. It is worth clarifying that many of the specialists who
work predominantly in the public assisted reproduction
services also work at private assisted reproduction clinics
(although this is not so the other way around). This means,
among other things, that people who attend the public
healthcare service might be seen by the same doctor as
someone who attends a private clinic. This also means that
the community of assisted reproduction professionals is not
clearly divided between those in the public sector and those
in the private sector. This ‘double-shift’ is quite common
within the Mexican healthcare system across all specialities;
a consequence, at least partially, of economic factors.
The public assisted reproduction service and
the private assisted reproduction clinic
Privately owned assisted reproduction clinics, which are
potentially lucrative businesses, are not subject to the same
restrictions imposed on publicly funded assisted reproduc-
tion services regarding, for example, patient eligibility, the
range of protocols offered and cost. Public assisted repro-
duction services operate within existing government-run
hospitals, which have limited infrastructure (e.g. space and
staff) and funding, and thus need to negotiate the resources
required to offer assisted reproductive technology within a
complex bureaucracy. This might be one of the reasons for
the limited range of protocols they offer (which varies
between health services), for restricting their services to
women under 35 who are in a heterosexual relationship, and
for the limited scope they have in offering the services at a
lower cost (since they are partially subsidised) (see Table 1).
The limitations they impose suggest, among other things, a
practical perspective, for they do not engage in gamete
donation, cryopreservation or surrogacy, all practices that
require extra material and bureaucratic infrastructure.
Private assisted reproduction clinics, on the other hand,
respond to a different, more capitalist, logic. Not only do
they offer a wider range of treatments without restrictions
in terms of gender or marital status, albeit at a higher cost
(see Table 1), but they also employ complex managerial and
marketing schemes, something previously unseen in Mexico
in the area of biomedical health services.As a first step, these schemes involve the creation of an
identity for the clinic. Many private assisted reproduction
clinics have a corporate-like identity. This identity, which is
not based on the reputation of the doctors that run them and
work in them, is constructed using a name, a logo and a
slogan which usually make reference to infertility, fertility,
motherhood, reproduction, genetics, gametes, pregnancy,
babies, hopes or desires. This separation between the
identity of the clinician and the identity of the clinic allows
a degree of independence between the clinic and the
physician, an independence which is also present in the
way the clinics operate: ‘due to the structure the new clinics
are taking, patients are no longer “the doctor’s patient”,
they are becoming “the clinic’s patients”’ (Head of Clinic,
field notes 2008). The clinic’s identity is then used as part of
a marketing scheme, which includes a presence in social
media (e.g. Facebook, Twitter and Pinterest), advertising in
the printed press (newspapers and magazines), on televi-
sion, radio, billboards and in public spaces (e.g. bus-stops).
These advertisements are coordinated by the PR department
and are part of a scheme that tends to rely on promissory
rhetoric (Sunder Rajan, 2007); for example, during promo-
tional events organized at conference venues with approx-
imately 500 attendees per session, free consultations are
offered as raffle prizes, discount vouchers are handed out
for future treatments, payment options are presented,
people are invited to share their testimonies of success and
the basic elements of assisted reproductive technology are
explained. It is in these last two activities above all where
the clinics frame the use of assisted reproductive technology
as something scientifically proven to work, both by quoting
information published in scientific journals and by present-
ing testimonies of success. This message of almost certain
success is then re-fuelled by media coverage of assisted
reproductive technology, which is usually very uncritical and
has mostly portrayed assisted reproductive technology as
highly successful, as is illustrated in the following two
examples, the first being a piece in a national newspaper
and the second being information from a clinic´s website:
As long as a woman has a uterus, she can achieve pregnancy,
even if she is in menopause, and with the technique we offer,
80% of the couples reach pregnancy in only 40 days. (Rivera,
2008).
You will have a baby at home, or your money back.’ ‘We are the
Latin-American clinic with the highest rate of success: 94% that
you will have a baby at home (sic Ingenes, http://www.ingenes.
com consulted the 1July, 2015)
These actions (the advertisements in the media and the
promotional events) have played an important role in
making assisted reproductive technology visible and they
have contributed to the construction, socialisation and
normalisation of these techniques. Because of the way
infertility is framed – in terms of causes and procedures to
overcome it – and the images that are used, established
gender roles, kinship bonds and the power of science are also
reaffirmed. The desire for children and the causes of
infertility continue to be placed predominantly on women;
however, there is a move towards lessening the importance
of a genetic link with the future baby (thus laying the ground
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great capacity of science and biomedical intervention in life
processes is praised.Regulating the assisted reproduction Industry
Currently, the Mexican assisted reproduction industry is
collaterally regulated by laws and guidelines established by
two federal bodies: CENATRA (National Transplant Centre)
and COFEPRIS. I call this collateral regulation because the
aspects of assisted reproduction overseen by CENATRA and
COFEPRIS only incidentally fall into their jurisdiction; they do
not have assisted reproduction-specific laws. CENATRA,
established in 2000, is responsible for administering organ
donation, and tissue and cell transplants through the National
Transplant Registry where donors, recipients, procedures and
the healthcare providers involved are recorded. Because
gametes are cells, they register the donation of germinal
cells (i.e. gametes). However, the infrastructure offered by
CENATRA for gamete donation registry is not robust (anyone
can upload data), hence the information they gather and
produce lacks solidity. Similarly, COFEPRIS was created in
2001 to issue licences allowing healthcare establishments to
deal with surgical and obstetric procedures and to handle
organs, tissues and cells. Recently, it has taken on the task of
conducting sanitary inspections of assisted reproduction
clinics. To date, COFEPRIS has registered 52 assisted repro-
duction clinics (GIRE, 2015) and, according to one physician, in
2016 they began a comprehensive campaign to verify that
assisted reproduction clinics are working to appropriate
standards (field-notes, 2016).
In addition to the regulations established by COFEPRIS and
CENATRA, there are some states within the federation that
have active articles, mostly in their civil codes, that oversee
specific aspects of assisted reproduction. These deal with
issues related to establishing kinship when using assisted
reproductive technology (in Aguascalientes, Colima, Morelos
and Sonora), surrogacy (in Tabasco) and embryo donation (in
Querétaro), as well as prohibiting the use of embryos for
research or cryopreserving them (in Coahuila) (GIRE, 2015).
Little attention had been given to the existence of these
articles until a debate surrounding surrogacy in Tabasco
emerged. The debate arose when the laws in Thailand and
India, traditionally considered as ‘the places to go’ for those
who needed surrogacy but could not access it in their own
country, became more restrictive. As a consequence, Tabasco
became the new ‘place to go’, due to its permissive laws. In
response, Tabasco’s laws were changed to allow only Mexican
nationals to use surrogates, thwarting the reproductive
tourism market that was on the brink of explosion.
However, the story of how policymakers and assisted
reproduction practitioners are trying to regulate these
services is more complex than this. There are at least four
interconnected arenas where regulation is being negotiated:
(i) presentation of proposals by various political parties;
(ii) expert forums organised by the Chamber of Deputies;
(iii) practical guidelines dictated by the professional com-
munity (which are not legally binding); and (iv) a standard of
practice currently under elaboration (which could be legally
binding). As is described in more detail below, in most ofthese efforts professionals and policymakers are working in
collaboration.Proposals for regulation
The first proposal to regulate the assisted reproduction
industry was presented by the then-emerging Green Party in
1999. Since then, each political party has presented its own
proposal, resulting in more than 20 by 2012, yet none has
been passed into law. Why this should be so is still under
research. Some physicians have speculated that it might be
because a law regarding assisted reproduction has no political
value, others think it might be due to certain potentially
controversial aspects covered these laws (e.g. the destiny
of untransferred embryos and the use of assisted reproduc-
tive technology by homosexual couples). Establishing how the
various proposals came into existence (for example, who came
up with the idea of writing one or how the different elements
were debated and agreed upon) is also still not clear. There
are, however, some elements that can help to begin to paint
a picture.
The first of these elements lies within the motivations and
justifications for the proposals. Most proposals start out by
expressing a certain level of apprehension with the develop-
ment of biotechnologies such as genetics and assisted
reproductive technology. Specifically, there is concern with
the use of these biotechnologies for purposes other than
granting infertile couples or individuals the opportunity to
procreate. This apprehension is justified because these
biotechnologies are considered capable of affecting the
reproductive and evolutionary process of humanity by offering
the possibility to manipulate gametes and embryos with
eugenic purposes. In addition to the social, ethical, juridical
and biomedical implications, the use of biotechnologies have
generated legal voids, both juridical and axiological, that
need to be addressed. In light of this, representatives of
several political parties have put forward different initiatives
with the purpose of updating the existing laws, at least to a
certain extent. Some proposals also mention the fact that
other countries have already legislated these procedures and
thus Mexico should do the same.
A second element can be found in their content. Most
initiatives seek to regulate the way assisted reproduction
services are offered and to control cloning and stem cell
research. All initiatives agree to allowing the use of most
assisted reproduction procedures (AI, GIFT, IVF, ICSI) when
being used to help a ‘traditional family’ have children using
their own gametes and the wife’s uterus. The structure of
this ‘traditional family’ can be inferred to be a stable
heterosexual couple (not necessarily legally married) where
the woman is aged between her early twenties and her early
forties. It is when this traditional family model is altered
that discrepancies between proposals appear: for example,
allowing same-sex couples, single or widowed users, gamete
or embryo donation, surrogacy or embryo selection (for
other than medical reasons). This could suggest that what
causes debate and disagreement is altering what is consid-
ered the ‘acceptable’ family structure. A third brush-stroke
that can add to the picture is the participation of some
physicians in the process of elaborating some of these
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did not appear in the official documents of the proposals.Expert forum
In 2001 the Chamber of Deputies organised an expert forum
with the purpose of helping policymakers understand the
medical and legal implications of assisted reproduction and
thus develop appropriate regulations for assisted reproduction
services (Galván Antillón, 2001). Seven different speakers
were invited to talk about causes of infertility, embryo
development, human genetics and the biological, technical,
bioethical and legal aspects of assisted reproductive technol-
ogy. Dr Gutierrez Najar, the leader of the team who achieved
the first Mexican IVF-conceived baby, was among these
experts. There were also two geneticists, one embryologist,
one bioethicist and one lawyer, but no users, psychologists
or nurses were invited. Although all speakers approved of the
use of assisted reproductive technology, traditional gender
roles and conservative Christian views were reproduced in
these presentations. A few years later a second forum, called
Assisted Reproduction in Mexico and its Expectations (Cámara
de Diputados, 2004) took place in four different cities
(Cuernavaca [Morelos], Monterrey [Nuevo León], Guanajuato
[Guanajuato] and Mexico City). As far as is known, evidence
that this forum had any effect, other than familiarising
policymakers with the topic, has not been published.Practical guidelines
In 2012, a group of assisted reproduction professionals from 34
centres, both public and private across the country, and one
member of a non-governmental organisation (NGO), were
organised into seven thematic groups to establish a National
Consensus document on assisted reproduction. This document
was published in two national biomedical journals simulta-
neously: in the Journal of the Society of Gynaecologists and
Obstetricians (Ginecología y Obstetricia de México) and in the
journal published by AMMR (Reproducción de México). The
themes covered were: patient eligibility, ovarian stimulation
protocols, ova aspiration, embryo transfer, hormonal support,
cryopreservation and informed consent. In the publication
they stipulate, for example, that single women or women in a
heterosexual or homosexual relationships (not necessarily
legally married) are eligible for assisted reproduction; that
when it is a couple soliciting the services, both members of the
couplemust give their consent for the procedures; and that the
destiny of surplus sperm, ova and embryos has to be clearly
stipulated in the consent form. The consensus considers the
possibility of donating or transferring non-used gametes and
embryos to other couples for reproductive use or using them for
scientific research (Kably-Ambe et al., 2012). Although the
consensus is not legally binding, it has great value because it
implies a collaboration between biomedical professionals –
who would more normally be competing with each other for
clients – to arrive at a unified perspective on how assisted
reproduction should be practiced. This is onemore in a series of
steps taken towards the professionalization and solidification
of this biomedical specialty (cf. González-Santos, 2014).Standards of practice
Currently, a new strategy is emerging regarding standards of
practice. Rather than generating a general comprehensive
law, assisted reproduction specialists (such as heads of clinics
and members of professional associations), in conjunction
with representatives of government offices (e.g. Ministry of
Health), members of private and public hospitals and NGO
are developing standards of practice for assisted reproduc-
tion services. This document is still under construction and
the outcome of it is still very much uncertain. The purpose
of this document is to establish a Mexican Official Norm
(NOM) or standard for assisted reproduction. Those that
already exist specify obligatory technical regulations, re-
quirements and specifications for goods and services and
cover a wide range of areas, including health services and
practices. If passed, this assisted reproduction NOM would
establish how diagnosis and treatment are conducted, the
minimal requirements for infrastructure, and for the profes-
sional profile of the staff.
It can be seen that policymakers and professionals
collaborate in three of the four arenas, although the
proportion and place each occupies differs. In the proposals
and forums the professionals are fewer and have less power,
while in the document for the standards of practice it is the
professionals who lead the discussion and outnumber the
non-biomedical contributors.
Conclusion
The purpose of this paper has been to offer an overview of
how assisted reproduction emerged and developed in Mexico
by addressing two broad questions: (i) When and how did
assisted reproductive technology become common practice
within the area of reproductive medicine? and (ii) How did
the Mexican assisted reproduction industry emerge? In doing
so, this study has traced the development of the Mexican
assisted reproduction industry from esterilología to repro-
ductive biology, from a clinical practice to a reproductive
industry, from individual doctors and their individual
practices, to networks of clinics (see Table 2 for a summary).
Throughout this narrative, certain aspects have been
highlighted that I consider were prominent in this process
and which are summarized below. First, this paper discussed
the way in which gynaecologists, from the 1940s to the
present day, have recognized and acknowledged the im-
portance of family – and thus of child bearing – within the
life of Mexicans, both as individuals and as a society. Second,
it pointed out that during the twentieth century, biomedi-
cine was concerned with and involved in the hormonal and
surgical control of reproduction, either to limit the number
of offspring or to help those who cannot reproduce unaided.
Third, it told the story of how Mexican gynaecologists came
into direct contact with those developing assisted reproduc-
tion techniques (specifically GIFT). These first three ele-
ments contributed strongly to what I call the epistemic shift
(Cámara de Diputados, 2004), which made the development
of assisted reproduction possible. Although I would not argue
that these elements were the only ones involved in this shift,
they are the ones that clearly made assisted reproductive
technology both accessible and acceptable to the
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duction professionals considered to be their subject of concern
– the legitimate questions or problems, the acceptable
answers and solutions, and the valid and viable methods to
deal with infertility. Within esterilología the question was
‘Why can’t this heterosexual couple achieve pregnancy after
coitus?’. This suggests that the subject was the heterosexual
couple, the accepted solution was to give the couple a
genetically linked baby and the accepted method was to fix
what was causing infertility in order to be able to achieve
non-assisted pregnancy, leaving in place the conditions for
further pregnancies to be non-assisted as well. In contrast,
within the framework of reproductive biology the question is
‘How can I help this person to have a baby?’ (as indicated by the
clinic’s slogans), the subject is the individual, their marital
status or sexual orientation is irrelevant in terms of eligibility,
the solution is to give the person a baby – a baby that does not
necessarily have to be genetically linked to either parent – and
the methods to achieve this can vary but do not imply curing
infertility. The family planning campaigns and the epistemo-
logical perspective brought from abroad by both local and
foreign physicians introduced a mind-set, which allowed
reproduction to be considered as a biotechnologically manip-
ulable matter and separated the couple from reproduction.
While, the three elements discussed above contributed to
the acceptance of assisted reproduction as a way of dealing
with infertility (dealing not being the same as curing), the
following ones contributed to the emergence of the assisted
reproduction industry. Assisted reproductive technology is
costly and complicated, and opening a clinic requires eco-
nomic investment and trained staff, hence for many aspiring
assisted reproduction specialists associating with colleagues
was necessary, and probably the only way of opening a private
clinic. This, together with the daily practical demands of the
assisted reproduction protocols, established the conditions for
clinicians to work as collaborating teams, giving rise to the
assisted reproduction clinic. This assisted reproduction clinic
became an entity, independent of the physician, making the
recipients of the treatments patients (clients) of the clinic,
rather than of the physician. Assisted reproduction clinics
acquired a name, a logo and a website and they adopted
marketing campaigns similar to those used by other businesses
(for example, the cosmetic surgery industry), but which
were not commonly used by individual physicians. All this
established a new way of practicing medicine. As described
earlier, the assisted reproduction industry has a particular way
of offering healthcare, one that is very different from other
sectors of healthcare. These particularities concern the way in
which service providers (physicians, nurses and biologists) and
users (patients) relate to each other, the clinics’ corporate-
like configuration and its use of marketing strategies. In
Mexico, patients and physicians were used to a face-to-face
interaction in a medical setting. Physicians, as professionals,
did not have a website, a Facebook page, a Pinterest profile
or a Twitter account. Now they advertise and interact with
patients online and through these social media portals. The
effects of this new way of relating requires further research
and perhaps even regulation, particularly considering what
is being said in marketing strategies; for example, some
clinics advertise by quoting high success rates and offering
deals where they assure ‘you get a baby or your money back’.
(Ingenes, television advertisement).This paper also looked at how a particular biotechnology
was adopted and adapted in one particular context. At
different points in Mexico’s assisted reproduction history,
different assisted reproductive technology treatments have
been crucial for its conformation. AI, for example, served to
frame infertility as an illness, as a condition that can be and
should be cured. This framing unified physicians dealing
with infertility to react against this procedure, which they
considered was merely a bypassing strategy and not a
technique for curing the condition. Years later, GIFT marked
the beginning of the high-complexity assisted reproductive
technology service, both because its developers participated
in the training of the first generations of assisted reproduction
specialists and because it was with this technique that Mexico
claimed its first successful case of medically assisted concep-
tion. Hence, in Mexico assisted reproduction has been more
than just IVF and the techniques that came after it, even if
today IVF and ICSI are the prominent techniques and GIFT is
hardly ever used (Zegers-Hochschild et al., 2016).
Finally, this paper also analysed the way in which assisted
reproduction is regulated in Mexico. It sought to highlight that
both assisted reproduction practitioners and non-practitioner
policymakers are engaged in the task of generating appropri-
ate regulations and guidelines for the offering of assisted
reproduction services. However, with the information avail-
able it has not been possible to determine why no regulation
has yet been agreed upon. Further research is needed in this
respect. Likewise, it has not been possible to examine closely
the controversial and shifting business of surrogacy, due
precisely to its volatility. Indeed, during the writing of this
paper, the Mexican state of Tabasco went from being a place
that had a flexible surrogacy law,making it attractive to those
interested in surrogacy (e.g. gay couples), to becoming yet
another location with a restrictive law imposed to limit
reproductive tourism.
This paper has laid out the first overview of how assisted
reproduction emerged and developed in Mexico. In doing so, it
has also identified areas that need further exploration. For
example, there is need for a more detailed analysis of the
professional biography of clinicians and biologists, to find out
where they were trained, to understand the reasons behind
the selection of a particularmodel for establishing a new clinic
(i.e. the network model or the outsourcing model), and to
track how the different clinical and laboratory practices were
developed. Likewise, we still need to follow closely the
regulatory efforts in order to see, on the one hand, how, if and
when a national regulatory framework is established, and on
the other, if and how individual practitioners and clinics follow
those professional guidelines that do exist.References
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